LS4 Lunch session: Sanofi – Mental Health: Sustainable Innovations for Neglected patients

LS4 Lunch session: Sanofi – Mental Health: Sustainable Innovations for Neglected patients

Invited Session
Location: Room 14 Date: April 20, 2016 Time: 12:30 pm - 2:00 pm

Background:

Despite the fact that mental disorders are the second leading cause of morbidity and mortality in developing countries, and that 4 mental illnesses are among the 10 leading causes of disability, access to mental health care remains particularly difficult in low and middle income countries, with 80% of people suffering from mental disorders who receive no treatment. .

Promoting an equitable access to care for people with mental disorders requires the active collaboration of all key stakeholders. Leveraging the complementary competencies of Health Ministries, Non-Governmental Organizations, Academics / Learned Societies and pharmaceutical companies can be a very effective way of developing innovative and sustainable solutions to address mental health challenges in developing countries.

 

General objective:

This lunch session will allow delegates to interact with various stakeholders, such as the President of “Alas pro Salud Mental” a Guatemalan NGO, a representative from the Ministry of Health of Morocco, the past President of the World Association of Social Psychiatry, a Vice President from the Pharmaceutical Company Sanofi, about opportunities and challenges concerning access to mental health care initiatives they have developed and implemented.

 

 

ID Name of the moderator Organisation Country
LS4/0

Martin Bernhardt

Sanofi

Switzerland

Presentations:

ID Title of the presentation Name of the speaker Organisation Country
LS4/1

Improving access to care for people with mental disorders in Guatemala: the point of view of a local NGO

Alejandro Paiz

NGO “Alas pro Salud Mental”

Guatemala

LS4/2

How can an international learned society help drive the paradigm shift?

Driss Moussaoui

World Association of Social Psychiatry

Morocco

LS4/3

Mental health in low and middle income countries: Which contribution from an international NGO?

Nicole Hanssen

NGO Santé Sud

France

LS4/3

What role for the pharmaceutical industry?

Robert Sebbag

Access to Medicines, Sanofi

France

 

logo